The short version
- Why people research itFocus, memory, neuroprotection, mood and stress resilience.
- What the evidence isReached phase 2 in humans for post-stroke apathy and depression.
- What to watchMuscle twitching, a seizure or sudden confusion.
How Nefiracetam works
Racetam that potentiates both nicotinic and NMDA receptor currents and enhances GABAergic transmission — a broader receptor profile than piracetam.
Nefiracetam is N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide: C14H18N2O2, molecular weight 246.30, XLogP 1.4, topological polar surface area 49.4 Å2 National Center for Biotechnology Information 2026. Structurally it is piracetam — the 2-oxopyrrolidine acetamide core is identical — with the terminal amide nitrogen carrying a 2,6-dimethylphenyl group instead of two hydrogens.
An identity warning that matters for anyone buying powder. Sunifiram is also C14H18N2O2 with a molecular weight of 246.30 National Center for Biotechnology Information 2026. A certificate of analysis showing mass 246.3 is consistent with either.
- Oral
On the goal map: Cholinergic — attention, encoding & recall (Focus, memory & cognition)
Research on Nefiracetam5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Human trials in post-stroke apathy and depression showed benefit; development was halted.
Human clinical evidence
Reached phase 2 in humans for post-stroke apathy and depression. Results were equivocal and development was discontinued; a separate program in Alzheimer's did not proceed either.
Which is part of why development stopped and is worth knowing.
Correlative data
Limited community use relative to the other racetams. Reported experience is of a mood-lifting effect more than a cognitive one, consistent with the apathy indication it was trialed for.
How the mechanism reads
Potentiates GABA-A and nicotinic acetylcholine receptors and enhances calcium channel currents — a broader receptor profile than the AMPA-focused racetams.
MechanisticThe GABAergic component is the likely explanation for the mood effect and distinguishes it mechanistically from the rest of the family.
Mechanistic
Sources
- Moriguchi S, Shioda N, Maejima H. Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor.. Mol Pharmacol 2007 · PMID 17095583
- Fujimaki Y, Sudo K, Hakusui H. J Pharm Pharmacol 1992 · PMID 1360528
- Fujimaki Y, Sudo K, Hakusui H. Pharmacokinetics of nefiracetam and three metabolites in humans and stereoselective hydroxylation of its pyrrolidine ring.. Xenobiotica 1993 · PMID 8484264
- Robinson RG, Jorge RE, Clarence-Smith K. Double-blind randomized treatment of poststroke depression using nefiracetam.. J Neuropsychiatry Clin Neurosci 2008 · PMID 18451188
- Robinson RG, Jorge RE, Clarence-Smith K. Double-blind treatment of apathy in patients with poststroke depression using nefiracetam.. J Neuropsychiatry Clin Neurosci 2009 · PMID 19622685
- Shimomura K, Shimada M, Hagiwara M. Testicular toxicity induced in dogs by nefiracetam, a neutrotransmission enhancer.. Reprod Toxicol 2004 · PMID 15082078
- National Center for Biotechnology Information. PubChem Compound Summary for CID 71157, Nefiracetam.. PubChem, retrieved 2026
- National Center for Biotechnology Information. PubChem Compound Summary for CID 4223812, Sunifiram.. PubChem, retrieved 2026
Nefiracetam safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Seizure disorder: potentiated NMDA and nicotinic currents can lower the firing threshold.
- Pregnancy or breastfeeding: no safety data on this racetam in either.
- Other racetams or nicotinic stimulants already in use: the receptor effects overlap and add.
- Moderate to severe liver impairment, since the drug is cleared by liver metabolism.
What’s expected
- A wider alertness and motivation lift than piracetam, from nicotinic and NMDA potentiation.
- Irritability or a wired feeling when the receptor drive is high.
- Headache, often tied to choline demand.
- Lighter sleep.
Watch for
- Muscle twitching, a seizure or sudden confusion.
- Marked agitation or panic.
- Rash or swelling after starting.
- Persistent nausea or stomach pain.
Labs that tell you it’s working
- Comprehensive Metabolic Panel (CMP)
- Magnesium
- Cortisol
- Vitamin B12 & Folate
Nefiracetam potentiates nicotinic and NMDA currents and boosts GABA release; the excitability and cholinergic load are the predicted risks. PMID 18451188 PMID 17095583
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Nefiracetam FAQ4 common questions
- Is Nefiracetam approved for human use?
- No. Nefiracetam is a research compound.
- What is Nefiracetam researched for?
- Focus, memory, neuroprotection, mood and stress resilience.
- Which labs show whether it's doing anything?
- Comprehensive Metabolic Panel; Magnesium; Cortisol; Vitamin B12 & Folate: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Nefiracetam: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



